KOR

e-Article

Intronic NEFH variant is associated with reduced risk for sporadic ALS and later age of disease onset.
Document Type
Article
Source
Scientific Reports. 8/30/2022, Vol. 12 Issue 1, p1-10. 10p.
Subject
*AGE of onset
*DELAYED onset of disease
*AMYOTROPHIC lateral sclerosis
*CREUTZFELDT-Jakob disease
*CYTOPLASMIC filaments
Language
ISSN
2045-2322
Abstract
Neurofilament heavy (NEFH) is one of the critical proteins required for the formation of the neuronal cytoskeleton and polymorphisms in NEFH are reported as a rare cause of sporadic ALS (sALS). In the current study, a candidate tetranucleotide (TTTA) repeat variant in NEFH was selected using an in-silico short structural variant (SSV) evaluation algorithm and investigated in two cohorts of North American sALS patients, both separately and combined (Duke cohort n = 138, Coriell cohort n = 333; combined cohort n = 471), compared to a group of healthy controls from the Coriell Institute biobank (n = 496). Stratification according to site of disease onset revealed that the 9 TTTA allele was associated with reduced disease risk, specifically confined to spinal-onset sALS patients in the Duke cohort (p = 0.001). Furthermore, carriage of the 10 TTTA allele was associated with a 2.7 year later age of disease onset in the larger combined sALS cohort (p = 0.02). These results suggest that the 9 and 10 TTTA motif length may have a protective advantage for potentially lowering the risk of sALS and delaying the age of disease onset, however, these results need to be replicated in larger multicenter and multi-ethnic cohorts. [ABSTRACT FROM AUTHOR]